Supplemental material
Leukemia & Lymphoma
Volume 64, 2023 - Issue 14
Open access
1,510
Views
0
CrossRef citations to date
0
Altmetric
Original Articles
Phase 1b dose-finding study of rituximab, lenalidomide, and ibrutinib (R2I) in patients with relapsed/refractory mantle cell lymphoma
Andrew Ipa Division of Oncology, Hackensack University Medical Center, Hackensack, NJ, USA;b Department of Oncology, Hackensack Meridian School of Medicine, Nutley, NJ, USA;c John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USACorrespondence[email protected]
View further author information
, View further author information
Alessandra Petrilloa Division of Oncology, Hackensack University Medical Center, Hackensack, NJ, USAView further author information
, Alexandra Della Piaa Division of Oncology, Hackensack University Medical Center, Hackensack, NJ, USA;c John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USAhttps://orcid.org/0000-0003-0875-6489View further author information
, Geeny G. Leea Division of Oncology, Hackensack University Medical Center, Hackensack, NJ, USA;d Department of Pharmacy Practice & Administration, Ernest Mario School of Pharmacy at Rutgers University, Piscataway, NJ, USAhttps://orcid.org/0000-0001-8145-3017View further author information
, Sarvarinder Gilla Division of Oncology, Hackensack University Medical Center, Hackensack, NJ, USAView further author information
, Tony Varughesea Division of Oncology, Hackensack University Medical Center, Hackensack, NJ, USAView further author information
, Joshua Zenreicha Division of Oncology, Hackensack University Medical Center, Hackensack, NJ, USA;c John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USAView further author information
, Martin Gutierreza Division of Oncology, Hackensack University Medical Center, Hackensack, NJ, USA;c John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USAView further author information
, Jiayu Zhangd Department of Pharmacy Practice & Administration, Ernest Mario School of Pharmacy at Rutgers University, Piscataway, NJ, USAView further author information
, Jaeil Ahne Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University, Washington, DC, USAView further author information
, Vishnu Bharanib Department of Oncology, Hackensack Meridian School of Medicine, Nutley, NJ, USAView further author information
, Ava S. Nejadb Department of Oncology, Hackensack Meridian School of Medicine, Nutley, NJ, USAView further author information
, Lauren Pascualc John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USAView further author information
, Tatyana A. Feldmana Division of Oncology, Hackensack University Medical Center, Hackensack, NJ, USA;b Department of Oncology, Hackensack Meridian School of Medicine, Nutley, NJ, USA;c John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USAView further author information
, Lori A. Lesliea Division of Oncology, Hackensack University Medical Center, Hackensack, NJ, USA;b Department of Oncology, Hackensack Meridian School of Medicine, Nutley, NJ, USA;c John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USAView further author information
& Andre H. Goya Division of Oncology, Hackensack University Medical Center, Hackensack, NJ, USA;b Department of Oncology, Hackensack Meridian School of Medicine, Nutley, NJ, USA;c John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USAView further author information
show all
Pages 2225-2235
|
Received 21 Aug 2023, Accepted 08 Sep 2023, Published online: 23 Sep 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.